Research Article
Diagnostic Performance of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Ventilator-Associated Pneumonia of Patients with Ischemic Stroke
Table 1
Characteristics of the study groups (mean ± SD/%/IQR).
| | Characteristics | All patients () | Patients with VAP () | Patients without VAP () | p |
| | Age, yrs | 70.27 ± 11.43 | 69.39 ± 10.84 | 70.89 ± 11.36 | 0.447 | | Male gender, (%) | 63 (47.7) | 37 (48.7) | 26 (46.4) | 0.861 | | Previous medical illness | | | | | | Cardiovascular disease, (%) | 70 (53.03) | 39 (51.31) | 31 (55.35) | 0.725 | | Cerebrovascular disease, (%) | 41 (31.06) | 23 (30.26) | 18 (32.14) | 0.851 | | Position of stroke | | | | | | TACI, (%) | 48 (36.36) | 29 (38.16) | 19 (33.93) | 0.715 | | POCI, (%) | 84 (63.64) | 47 (61.84) | 37 (66.07) | 0.715 | | Smoking history | 39 (29.55) | 24 (31.58) | 15 (26.78) | 0.571 | | Hypoproteinemia | 32 (24.24) | 17 (22.37) | 15 (26.79) | 0.682 | | APACHE II | 17.92 ± 4.94 | 18.21 ± 5.48 | 17.52 ± 4.88 | 0.442 | | GCS | 5.71 ± 2.27 | 5.82 ± 2.35 | 5.69 ± 2.78 | 0.085 | | mCPIS | 3.42 ± 1.45 | 3.37 ± 1.28 | 3.45 ± 1.61 | 0.751 | | PO2/FiO2 (mmHg) | 112.67 ± 50.11 | 115.75 ± 48.58 | 108.92 ± 52.78 | 0.443 |
|
|
TACI, total anterior circulation infarcts; POCI, posterior circulation infarcts; APACHE II, acute physiology and chronic health evaluation; GCS, Glasgow Coma Scale; mCPIS, modified clinical pulmonary infection score.
|
